Form SC 13D/A Playa Hotels & Resorts Filed by: FARALLON CAPITAL MANAGEMENT LLC May 21, 2021 02:01PM
Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31 May 17, 2021 09:01AM
Form 13F-NT Farallon Capital Europe For: Mar 31 May 17, 2021 09:01AM
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31 May 17, 2021 09:01AM
Form SC 13G Big Sky Growth Partners, Filed by: Farallon Capital Partners, L.P. May 10, 2021 06:02AM
View Older Stories

May 10, 2021 06:02AM Form SC 13G Decarbonization Plus Filed by: Farallon Capital Partners, L.P.
May 10, 2021 06:02AM Form SC 13G ARYA Sciences Acquisitio Filed by: Farallon Capital Partners, L.P.
May 10, 2021 06:02AM Form SC 13G Disruptive Acquisition Filed by: Farallon Capital Partners, L.P.
Apr 30, 2021 05:30PM Form SC 13G Khosla Ventures Acquisit Filed by: Farallon Capital Partners, L.P.
Apr 7, 2021 08:07AM Better Therapeutics to Become Publicly Traded via Merger with Mountain Crest Acquisition Corp. II (MCAD)
Apr 7, 2021 08:02AM Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Crest Acquisition Corp. II
Mar 31, 2021 05:06PM Form SC 13G Khosla Ventures Acquisit Filed by: FARALLON CAPITAL MANAGEMENT LLC
Mar 29, 2021 07:01AM SomaLogic to Combine with SPAC CM Life Sciences II (CMIIU)
Mar 29, 2021 07:00AM SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical Applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform
Mar 25, 2021 06:02AM Form SC 13G Longboard Pharmaceutical Filed by: FARALLON CAPITAL MANAGEMENT LLC
Mar 24, 2021 03:38AM Activist-backed proposal for Toshiba probe received 58% of shareholder votes
Mar 17, 2021 10:25PM Shareholder Votes at Toshiba EGM Represent Clear Mandate for Greater Transparency and Accountability
Mar 17, 2021 10:18PM Toshiba shareholders vote for probe in landmark win for Japan corporate governance
Mar 16, 2021 08:00AM Ventyx Biosciences Doses First Subject in a Phase 1 Trial of VTX-958, a Selective Allosteric TYK2 Inhibitor for Autoimmune Diseases
Mar 16, 2021 07:46AM Activist Toshiba shareholders tipped to win crucial vote on independent probe this week
Mar 15, 2021 06:35AM POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I (RACA)
Mar 15, 2021 06:00AM Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
Mar 15, 2021 06:00AM Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
Mar 14, 2021 11:43PM Farallon Urges Toshiba Shareholders to Make Their Voices Heard at Upcoming EGM
Mar 12, 2021 10:32AM Form D/A FARALLON CAPITAL OFFSHOR
Mar 12, 2021 10:10AM Form D/A Farallon Capital Partner
Mar 12, 2021 10:06AM Form D/A Farallon Capital (AM)
Mar 12, 2021 10:05AM Form D/A Farallon Capital Institu
Mar 9, 2021 09:09AM New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million
Mar 9, 2021 08:00AM Ventyx Biosciences Raises $114 Million Financing led by venBio Partners to Advance Diverse Pipeline of Immunology Programs
Mar 4, 2021 09:46PM CORRECTING and REPLACING Glass Lewis Recommends Toshiba Shareholders Vote FOR Farallon Proposal
Mar 4, 2021 09:57PM Top Toshiba shareholder gets further support for proposed investigation
Mar 4, 2021 09:46PM Glass Lewis Recommends Toshiba Shareholders Vote FOR Farallon Proposal
Mar 4, 2021 04:32AM BlackRock builds 5% stake in Toshiba, becomes third largest shareholder
Mar 3, 2021 09:21AM Farallon Comments on ISS Report Confirming Need for Toshiba to Rebuild Investor Trust
Mar 3, 2021 08:00AM Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline
Mar 2, 2021 09:00PM Proxy adviser ISS backs shareholder proposal for Toshiba investigation
Mar 2, 2021 11:01AM U.S. hedge fund Farallon accuses Toshiba of 'backpedaling' on strategy
Mar 2, 2021 08:47AM Farallon Capital Management Issues Letter to Toshiba Shareholders
Mar 2, 2021 08:00AM eGenesis Announces $125 Million Series C Financing
Mar 2, 2021 07:00AM Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
Mar 2, 2021 07:00AM Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
Mar 1, 2021 07:00AM FogPharma® Announces $107 Million Series C Financing to Advance Direct β-Catenin Antagonist and Universal Druggability™ Platform
Feb 24, 2021 01:29AM Top Toshiba shareholder renews call for probe over AGM vote
Feb 17, 2021 04:53AM Toshiba says no evidence it pressured Harvard over AGM vote
Feb 16, 2021 09:24AM Form 13F-NT Farallon Capital Europe For: Dec 31
Feb 16, 2021 09:23AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Feb 16, 2021 09:18AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
Feb 16, 2021 09:17AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 16, 2021 08:00AM SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Feb 16, 2021 06:43AM Form SC 13G/A Broadmark Realty Capital Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 16, 2021 06:43AM Form SC 13G/A AMYRIS, INC. Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 16, 2021 06:29AM Form SC 13G/A DermTech, Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 16, 2021 06:28AM Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 16, 2021 06:23AM Form SC 13G/A Savara Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
View Older Stories